Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05332717 · ClinicalTrials.gov registry record · NA
TKA Melatonin and Sleep Quality
A NA study, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- NA
- Development phase
- 176
- Enrollment target
NCT05332717 is a NA study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 176 participants.
The verdict
NCT05332717, a NA study, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 176 participants
- Enrollment target
Study Summary
This randomized controlled trial (RCT) will compare the effects of melatonin vs. placebo in patients undergoing primary total knee arthroplasty (TKA). This RCT aims to study the effects melatonin has on sleep quality after TKA. Patients will be blinded to their respective groups and will be instructed to take either 5mg melatonin or a placebo pill (Vitamin C) for 6 weeks postoperative. Sleep quality surveys will be administered preoperatively and post-operative week 6, 90-days and 1 year. Poor sleep quality is a common issue faced by patients undergoing TKA. The goal of this study is see if melatonin can improve postoperative sleep quality, and if so, does improved sleep quality correlate to improvements in other postoperative outcomes.
Interventions
- DIETARY_SUPPLEMENT Melatonin 5 mg
- DIETARY_SUPPLEMENT Placebo (Vitamin C)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2022-01-10 |
| Est. Completion | 2022-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05332717
The ClinicalTrials.gov registry entry for NCT05332717 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 176 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Melatonin 5 mg is the first listed.
NCT05332717 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05332717 about?
NCT05332717 is a clinical study titled "TKA Melatonin and Sleep Quality". This randomized controlled trial (RCT) will compare the effects of melatonin vs. placebo in patients undergoing primary total knee arthroplasty (TKA). This RCT aims to study the effects melatonin has on sleep quality after TKA. Patients will be blinded to their respective groups and will be instruct...
What is the current status of trial NCT05332717?
This trial is currently completed. It is a NA study. The enrollment target is 176 participants. The study started on 2022-01-10. Estimated completion is 2022-04-30.
What interventions are being tested in trial NCT05332717?
The interventions under investigation include: Melatonin 5 mg (DIETARY_SUPPLEMENT), Placebo (Vitamin C) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05332717?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.